Literature DB >> 21881491

Structural studies of the actions of anesthetic drugs on the γ-aminobutyric acid type A receptor.

Gustav Akk1, Joe Henry Steinbach.   

Abstract

The γ-aminobutyric acid type A receptor is the major transmitter-gated inhibitory channel in the central nervous system. The receptor is a target for anesthetics, anticonvulsants, anxiolytics, and sedatives whose actions facilitate the flow of chloride ions through the channel and enhance the inhibitory tone in the brain. Both the kinetic and structural aspects of the actions of modulators of the γ-aminobutyric acid type A receptor are of great importance to understanding the molecular mechanisms of general anesthesia. In this review, the structural rearrangements that take place in the γ-aminobutyric acid type A receptor during channel activation and modulation are described, focusing on data obtained using voltage-clamp fluorometry. Voltage-clamp fluorometry entails the binding of an environmentally sensitive fluorophore molecule to a site of interest in the receptor, and measurement of changes in the fluorescence signal resulting from activation- or modulation-elicited structural changes. Detailed investigations can provide a map of structural changes that underlie or accompany the functional effects of modulators.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881491      PMCID: PMC3226907          DOI: 10.1097/ALN.0b013e3182315d93

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  54 in total

1.  Structural domains of the human GABAA receptor 3 subunit involved in the actions of pentobarbital.

Authors:  R Serafini; J Bracamontes; J H Steinbach
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

Review 2.  Structural elements involved in activation of the gamma-aminobutyric acid type A (GABAA) receptor.

Authors:  T L Kash; J R Trudell; N L Harrison
Journal:  Biochem Soc Trans       Date:  2004-06       Impact factor: 5.407

3.  Substituted-cysteine accessibility method.

Authors:  A Karlin; M H Akabas
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

4.  GABAA receptor subunit gamma2 and delta subtypes confer unique kinetic properties on recombinant GABAA receptor currents in mouse fibroblasts.

Authors:  K F Haas; R L Macdonald
Journal:  J Physiol       Date:  1999-01-01       Impact factor: 5.182

Review 5.  The benzodiazepine binding site of GABAA receptors.

Authors:  E Sigel; A Buhr
Journal:  Trends Pharmacol Sci       Date:  1997-11       Impact factor: 14.819

6.  Activation and block of recombinant GABA(A) receptors by pentobarbitone: a single-channel study.

Authors:  G Akk; J H Steinbach
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

7.  Direct physical measure of conformational rearrangement underlying potassium channel gating.

Authors:  L M Mannuzzu; M M Moronne; E Y Isacoff
Journal:  Science       Date:  1996-01-12       Impact factor: 47.728

Review 8.  GABA(A) receptor subtypes underlying general anesthesia.

Authors:  Robert P Bonin; Beverley A Orser
Journal:  Pharmacol Biochem Behav       Date:  2008-01-16       Impact factor: 3.533

9.  Dependence of the GABAA receptor gating kinetics on the alpha-subunit isoform: implications for structure-function relations and synaptic transmission.

Authors:  K J Gingrich; W A Roberts; R S Kass
Journal:  J Physiol       Date:  1995-12-01       Impact factor: 5.182

10.  Electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates.

Authors:  D A Stauffer; A Karlin
Journal:  Biochemistry       Date:  1994-06-07       Impact factor: 3.162

View more
  8 in total

Review 1.  Comparison of αβδ and αβγ GABAA receptors: Allosteric modulation and identification of subunit arrangement by site-selective general anesthetics.

Authors:  Hua-Jun Feng; Stuart A Forman
Journal:  Pharmacol Res       Date:  2017-12-30       Impact factor: 7.658

2.  Modulation of the human ρ1 GABAA receptor by inhibitory steroids.

Authors:  Megan M Eaton; You Bin Lim; Douglas F Covey; Gustav Akk
Journal:  Psychopharmacology (Berl)       Date:  2013-12-07       Impact factor: 4.530

3.  Etomidate produces similar allosteric modulation in α1β3δ and α1β3γ2L GABA(A) receptors.

Authors:  H-J Feng; Y Jounaidi; M Haburcak; X Yang; S A Forman
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 4.  Using Xenopus oocytes in neurological disease drug discovery.

Authors:  Steven L Zeng; Leland C Sudlow; Mikhail Y Berezin
Journal:  Expert Opin Drug Discov       Date:  2019-11-01       Impact factor: 6.098

5.  Mutational Analysis at Intersubunit Interfaces of an Anionic Glutamate Receptor Reveals a Key Interaction Important for Channel Gating by Ivermectin.

Authors:  Nurit Degani-Katzav; Revital Gortler; Marina Weissman; Yoav Paas
Journal:  Front Mol Neurosci       Date:  2017-04-06       Impact factor: 5.639

6.  Trapping of ivermectin by a pentameric ligand-gated ion channel upon open-to-closed isomerization.

Authors:  Nurit Degani-Katzav; Moshe Klein; Moran Har-Even; Revital Gortler; Ruthi Tobi; Yoav Paas
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

7.  High-Dose Benzodiazepines Positively Modulate GABAA Receptors via a Flumazenil-Insensitive Mechanism.

Authors:  Na Wang; Jingjing Lian; Yanqing Cao; Alai Muheyati; Shanshan Yuan; Yujie Ma; Shuzhuo Zhang; Gang Yu; Ruibin Su
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

8.  Caenorhabditis elegans neuromuscular junction: GABA receptors and ivermectin action.

Authors:  Guillermina Hernando; Cecilia Bouzat
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.